The Discounted Cash Flow (DCF) valuation of Tibet Weixinkang Medicine Co Ltd (603676.SS) is 15.35 CNY. With the latest stock price at 14.06 CNY, the upside of Tibet Weixinkang Medicine Co Ltd based on DCF is 9.2%.
Based on the latest price of 14.06 CNY and our DCF valuation, Tibet Weixinkang Medicine Co Ltd (603676.SS) is a buy. buying 603676.SS stocks now will result in a potential gain of 9.2%.
| Range | Selected | |
| WACC / Discount Rate | 9.4% - 11.7% | 10.5% |
| Long-term Growth Rate | 2.5% - 4.5% | 3.5% |
| Fair Price | 12.27 - 21.14 | 15.35 |
| Upside | -12.7% - 50.4% | 9.2% |